C. Brard

Bayesian survival analysis in clinical trials: What methods are used in practice?

Lisa V. Hampson, G. Le Teuff, L. Hampson, 2017, Clinical trials.

355 Pembrolizumab and bevacizumab in platinum resistant epithelial ovarian cancer patients

C. Genestie, A. Paci, C. Balleyguier, 2021, Journal for ImmunoTherapy of Cancer.

Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial

N. André, X. Paoletti, B. Geoerger, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma

J. Adam, S. Warren, S. Shen, 2021, Clinical Cancer Research.

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.

N. André, X. Paoletti, B. Geoerger, 2021, European journal of cancer.

Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium.

N. André, X. Paoletti, B. Geoerger, 2021, European journal of cancer.

Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma

Lisa V. Hampson, G. Le Teuff, S. Piperno-Neumann, 2019, BMJ Open.

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre.

G. Le Teuff, B. Escudier, N. Lassau, 2017, European journal of cancer.

Pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with platinum-resistant epithelial ovarian cancer.

C. Genestie, S. Broutin, C. Balleyguier, 2021 .

Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study

Caroline Brard, Lisa V. Hampson, Nathalie Gaspar, 2019, BMC Medical Research Methodology.

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre.

G. Le Teuff, B. Escudier, N. Lassau, 2017, European journal of cancer.